Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Sukhbinder K. Dhesy-Thind
Based on 14 articles published since 2009
(Why 14 articles?)
||||
Expertise Level
The expertise of Sukhbinder K. Dhesy-Thind ranks in the
  • Top 0.16%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 14 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Dhesy-Thind, Sukhbinder K   ·   Dhesy-Thind, S K   ·   Dhesy-Thind, S   ·   Dhesy-Thind, Sukhbinder
Work Locations
Details
Most likely:    McMaster University   Contact    
2018
  • Department of Medicine, Sunnybrook Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N3M5, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Canada. · McMaster University, Hamilton, ON, Canada. · Department of Medicine, Sunnybrook Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N3M5, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Canada. · Department of Pathology, University of Toronto, Toronto, ON, Canada. · Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. · Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. · Pubmed 29915948
2017
  • Sukhbinder Dhesy-Thind, Juravinski Cancer Centre · Sukhbinder Dhesy-Thind and Glenn G. Fletcher, McMaster University, Hamilton, Ontario · Phillip S. Blanchette, Sunnybrook Odette Cancer Centre · Sonal Gandhi, Sunnybrook Health Sciences, Toronto, Ontario · Mark J. Clemons, The Ottawa Hospital Cancer Centre, Ottawa, Ontario · Rasna Gupta, Windsor Regional Cancer Program, Windsor, Ontario · Mihaela Mates, Kingston General Hospital, Kingston, Ontario · Ted Vandenberg, London Health Sciences Centre, London, Ontario, Canada · Melissa S. Dillmon, Harbin Clinic, Rome, GA · Elizabeth S. Frank, Lexington · Beverly Moy, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA · and Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI. · Pubmed 28618241
  • Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, 1280 Main Street West, MDCL 4015, Hamilton, ON, Canada. · Cellular Therapy and Cancer Immunology Program, Department of Hematology/Oncology and BMT, Nationwide Children's Hospital, The Ohio State University Comprehensive Cancer Center, Ohio, USA. · Department of Oncology, McMaster University, Hamilton, ON, Canada. · Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, 1280 Main Street West, MDCL 4015, Hamilton, ON, Canada. · Pubmed 28668076
  • Sukhbinder Dhesy-Thind, Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada · Glenn G. Fletcher, McMaster University, Hamilton, Ontario, Canada · Mark Clemons, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada · and Catherine Van Poznak, University of Michigan, Ann Arbor, MI. · Pubmed 28654367
2015
  • Department of Medicine, McMaster University, Health Sciences Center Rm 3H1E, Hamilton, ON, Canada. · Department of Molecular Medicine & Pathology, McMaster University, Hamilton, ON, Canada. · Affiliate Scientist, Toronto General Research Institute, Toronto, ON, Canada. · Department of Oncology, McMaster University and Juravinski Cancer Center, Hamilton, ON, Canada. · Pubmed 26011475
2014
  • Department of Medicine, McMaster University, Health Sciences Center Rm 3H1E, Hamilton, ON, Canada; Department of Molecular Medicine & Pathology, McMaster University, Hamilton, ON, Canada; Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Toronto General Research Institute, Toronto, ON, Canada. · Pubmed 25041579
Probable:    Miscellaneous institutions in Hamilton      
2018
  • BC Cancer Agency, Victoria, BC, V8R 6V5, Canada. · BC Cancer Agency, Kelowna, BC, Canada. · Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Canadian Cancer Trials Group, Kingston, ON, Canada. · Cancer Centre of Southeastern Ontario, Kingston, ON, Canada. · Juravinski Cancer Centre, Hamilton, ON, Canada. · Jewish General Hospital, Montreal, QC, Canada. · BC Cancer Agency, Vancouver, BC, Canada. · Allan Blair Cancer Centre, Regina, SK, Canada. · BC Cancer Agency, Victoria, BC, V8R 6V5, Canada. · Queens University, Kingston, ON, Canada. · Pubmed 29027598
Probable:    Hamilton Health Sciences      
2016
  • Division of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Room 457A, 1276 South Park Street, Bethune Building, Halifax, NS, B3H 2Y9, Canada. · Tom Baker Cancer Centre, Calgary, AB, Canada. · London Regional Cancer Program, London, ON, UK. · Ottawa Hospital Research Institute, Ottawa, ON, Canada. · BCCA-Vancouver Cancer Centre, Vancouver, BC, Canada. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · BCCA-Cancer Centre for the Southern Interior, Kelowna, BC, Canada. · Hopital Charles LeMoyne, Greenfield Park, QC, Canada. · Allan Blair Cancer Centre, Regina, SK, Canada. · Queen's University, Kingston General Hospital, Kingston, ON, Canada. · Henry Ford Health System, Detroit, MI, USA. · University Health Network-OCI/Princess Margaret Hospital, Toronto, ON, Canada. · Canadian Cancer Trials Group (CCTG), Queen's University, Kingston, CA, Canada. · Pubmed 27116183
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 14 total) written by Sukhbinder K. Dhesy-Thind about Breast Neoplasms:

  • A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213. 2018
  • Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study. 2018
  • Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update. 2017
  • Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline. 2017
  • Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours. 2017
  • Reply to T.J. Powles et al. 2017
  • Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer. 2016
  • The Receptor for the CD200 Tolerance-Signaling Molecule Associated with Successful Pregnancy is Expressed by Early-Stage Breast Cancer Cells in 80% of Patients and by Term Placental Trophoblasts. 2015
  • Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications. 2015
  • The CD200-tolerance signaling molecule associated with pregnancy success is present in patients with early-stage breast cancer but does not favor nodal metastasis. 2014
Show List of Full Article Records
Google Searches

Learn more about Sukhbinder K. Dhesy-Thind using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
McMaster University
Miscellaneous institutions in Hamilton
Hamilton Health Sciences
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
McMaster University
2018
  • Department of Medicine, Sunnybrook Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N3M5, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Canada. · McMaster University, Hamilton, ON, Canada. · Department of Medicine, Sunnybrook Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N3M5, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Canada. · Department of Pathology, University of Toronto, Toronto, ON, Canada. · Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. · Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. · Pubmed 29915948
2017
  • Sukhbinder Dhesy-Thind, Juravinski Cancer Centre · Sukhbinder Dhesy-Thind and Glenn G. Fletcher, McMaster University, Hamilton, Ontario · Phillip S. Blanchette, Sunnybrook Odette Cancer Centre · Sonal Gandhi, Sunnybrook Health Sciences, Toronto, Ontario · Mark J. Clemons, The Ottawa Hospital Cancer Centre, Ottawa, Ontario · Rasna Gupta, Windsor Regional Cancer Program, Windsor, Ontario · Mihaela Mates, Kingston General Hospital, Kingston, Ontario · Ted Vandenberg, London Health Sciences Centre, London, Ontario, Canada · Melissa S. Dillmon, Harbin Clinic, Rome, GA · Elizabeth S. Frank, Lexington · Beverly Moy, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA · and Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI. · Pubmed 28618241
  • Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, 1280 Main Street West, MDCL 4015, Hamilton, ON, Canada. · Cellular Therapy and Cancer Immunology Program, Department of Hematology/Oncology and BMT, Nationwide Children's Hospital, The Ohio State University Comprehensive Cancer Center, Ohio, USA. · Department of Oncology, McMaster University, Hamilton, ON, Canada. · Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, 1280 Main Street West, MDCL 4015, Hamilton, ON, Canada. · Pubmed 28668076
  • Sukhbinder Dhesy-Thind, Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada · Glenn G. Fletcher, McMaster University, Hamilton, Ontario, Canada · Mark Clemons, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada · and Catherine Van Poznak, University of Michigan, Ann Arbor, MI. · Pubmed 28654367
2015
  • Department of Medicine, McMaster University, Health Sciences Center Rm 3H1E, Hamilton, ON, Canada. · Department of Molecular Medicine & Pathology, McMaster University, Hamilton, ON, Canada. · Affiliate Scientist, Toronto General Research Institute, Toronto, ON, Canada. · Department of Oncology, McMaster University and Juravinski Cancer Center, Hamilton, ON, Canada. · Pubmed 26011475
2014
  • Department of Medicine, McMaster University, Health Sciences Center Rm 3H1E, Hamilton, ON, Canada; Department of Molecular Medicine & Pathology, McMaster University, Hamilton, ON, Canada; Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Toronto General Research Institute, Toronto, ON, Canada. · Pubmed 25041579
Miscellaneous institutions in Hamilton
2018
  • BC Cancer Agency, Victoria, BC, V8R 6V5, Canada. · BC Cancer Agency, Kelowna, BC, Canada. · Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Canadian Cancer Trials Group, Kingston, ON, Canada. · Cancer Centre of Southeastern Ontario, Kingston, ON, Canada. · Juravinski Cancer Centre, Hamilton, ON, Canada. · Jewish General Hospital, Montreal, QC, Canada. · BC Cancer Agency, Vancouver, BC, Canada. · Allan Blair Cancer Centre, Regina, SK, Canada. · BC Cancer Agency, Victoria, BC, V8R 6V5, Canada. · Queens University, Kingston, ON, Canada. · Pubmed 29027598
Unspecified
2017
  • Catherine Van Poznak, J. Sybil Biermann, and Reshma Jagsi, University of Michigan, Ann Arbor, MI · Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA · William E. Barlow, Cancer Research and Biostatistics, Seattle, WA · Linda D. Bosserman, City of Hope, Duarte, CA · Mark J. Clemons, The Ottawa Hospital Cancer Centre, Ottawa · Sukhbinder K. Dhesy-Thind, Juravinski Hospital and Cancer Centre, Hamilton · Andrea Eisen, Theodore A. Vandenberg, London Regional Cancer Program, London, Ontario, Canada · Melissa S. Dillmon, Harbin Clinic, Rome, GA · Elizabeth S. Frank, Dana-Farber Cancer Institute · Rachel Jimenez, Beverly Moy, Massachusetts General Hospital, Boston, MA · Richard L. Theriault, MD Anderson Cancer Center, Houston, TX · and Gary C. Yee, University of Nebraska Medical Center, Omaha, NE. · Pubmed 29035643
  • Sukhbinder Dhesy-Thind, Juravinski Cancer Centre · Sukhbinder Dhesy-Thind and Glenn G. Fletcher, McMaster University, Hamilton, Ontario · Phillip S. Blanchette, Sunnybrook Odette Cancer Centre · Sonal Gandhi, Sunnybrook Health Sciences, Toronto, Ontario · Mark J. Clemons, The Ottawa Hospital Cancer Centre, Ottawa, Ontario · Rasna Gupta, Windsor Regional Cancer Program, Windsor, Ontario · Mihaela Mates, Kingston General Hospital, Kingston, Ontario · Ted Vandenberg, London Health Sciences Centre, London, Ontario, Canada · Melissa S. Dillmon, Harbin Clinic, Rome, GA · Elizabeth S. Frank, Lexington · Beverly Moy, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA · and Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI. · Pubmed 28618241
Hamilton Health Sciences
2016
  • Division of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Room 457A, 1276 South Park Street, Bethune Building, Halifax, NS, B3H 2Y9, Canada. · Tom Baker Cancer Centre, Calgary, AB, Canada. · London Regional Cancer Program, London, ON, UK. · Ottawa Hospital Research Institute, Ottawa, ON, Canada. · BCCA-Vancouver Cancer Centre, Vancouver, BC, Canada. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · BCCA-Cancer Centre for the Southern Interior, Kelowna, BC, Canada. · Hopital Charles LeMoyne, Greenfield Park, QC, Canada. · Allan Blair Cancer Centre, Regina, SK, Canada. · Queen's University, Kingston General Hospital, Kingston, ON, Canada. · Henry Ford Health System, Detroit, MI, USA. · University Health Network-OCI/Princess Margaret Hospital, Toronto, ON, Canada. · Canadian Cancer Trials Group (CCTG), Queen's University, Kingston, CA, Canada. · Pubmed 27116183
University of Toronto
2015
  • Department of Medicine, University of Toronto, 27 King's College Cir, Toronto, ON, M5S 1A1, Canada. · Pubmed 25542270
2014
  • Department of Medicine, McMaster University, Health Sciences Center Rm 3H1E, Hamilton, ON, Canada; Department of Molecular Medicine & Pathology, McMaster University, Hamilton, ON, Canada; Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Toronto General Research Institute, Toronto, ON, Canada. · Pubmed 25041579
2012
  • Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Pubmed 22608362
  • Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, Toronto, Canada. · Pubmed 22505008
University Health Network of Toronto
2014
  • Department of Medicine, McMaster University, Health Sciences Center Rm 3H1E, Hamilton, ON, Canada; Department of Molecular Medicine & Pathology, McMaster University, Hamilton, ON, Canada; Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Toronto General Research Institute, Toronto, ON, Canada. · Pubmed 25041579
Yearly article counts 02412103100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.